Thank you for supporting journalism at your local newspaper. This article is available exclusively for our subscribers, who help fund our work at Navarre Press.
GAINESVILLE — Recognizing growing evidence that inflammation influences many diseases — including diabetes, certain cancers and even Alzheimer’s — University of Florida Health has established the Center for Inflammation and Mucosal Immunology to foster collaboration among members of the UF biomedical research community with shared interest in inflammation and disease.
Mansour Mohamadzadeh, Ph.D., and researchers have developed a mutant form of bacteria that, when administered orally to mice, reversed ulcerative colitis and even full blown colon cancer. The bacteria, L. acidophilus, normally plays a beneficial pro-biotic role in both animal and human digestive tracts, but when researchers tweaked certain genes and introduced the mutant bacteria to the diseased large intestines of mice, its presence hit the autoimmune system’s reset button to halt abnormal inflammation, dramatically reduce the number of precancerous polyps and even reverse progression of cancerous lesions. This finding has life-saving implications for the tens of thousands of Americans diagnosed each year with colon cancer, the second leading cause of cancer deaths in the U.S. It also has applications for the treatment of other autoimmune conditions, including HIV, Sjögrens disease, and diabetes.
The remainder of this article is available only for our website subscribers, who help fund our mission of keeping you updated on news you want and need to know. You can become a subscriber for as little as $5.67 a month.
